Breast Cancer Canada + AstraZeneca Canada Matched Research Awards: Advancing Progress in Survivorship

Breast Cancer Canada + AstraZeneca Canada Matched Research Awards: Advancing Progress in Survivorship is sponsored by Breast Cancer Canada, in partnership with AstraZeneca Canada. This funding supports innovative, Canadian-led research that addresses critical gaps following primary breast cancer treatment, with an emphasis on real-world impact and improved patient outcomes.

Apply For Grant Funding - Breast Cancer Canada Current Call for Proposals / Nominations Breast Cancer Canada + AstraZeneca Canada Advancing Progress in Survivorship Breast Cancer Canada, in partnership with AstraZeneca Canada , is now accepting applications for two matched research awards focused on improving breast cancer survivorship care across Canada.

This funding supports innovative, Canadian-led research that addresses critical gaps following primary treatment, with an emphasis on real-world impact and improved patient outcomes.

We are seeking proposals focused on: Survivorship surveillance and diagnostics Therapeutic interventions in post-treatment care New care delivery models that improve transitions between community and specialty services 2 awards of $100,000 CAD each Research must be conducted in Canada No institutional overhead permitted LOI Deadline: July 31, 2026 Download the application package here .

Breast Cancer Canada + McPeak-Sirois Group 2026 Canadian Breast Cancer Innovative Investigator-Initiated Clinical Trials Championship Breast Cancer Canada, in partnership with the McPeak-Sirois Group, is now accepting self-nominations for the 2026 Canadian Breast Cancer Innovative Investigator-Initiated Clinical Trials Championship.

This national initiative recognizes innovative investigator-initiated clinical breast cancer research and celebrates the teams advancing progress in patient care and clinical research.

We are seeking self-nominations from those with demonstrate excellence in: Clinical innovation in breast cancer care Patient-centred trial design and engagement Equitable access, including participation from underserved or rural populations 1 award of $10,000 CAD: The winning investigator and associated research institute may choose one of two funding formats: Full Scholarship: Support to send a designated research coordinator or nurse to a major scientific meeting such as ASCO, ESMO, or SABCS.

Institutional Grant: direct award to the research centre or institution to support professional development, workflow efficiency, and clinical research capacity. Self-Nomination Deadline: September 15, 2026 Download the nomination form here . Formulaire en français ici Breast Cancer Canada stands as the sole national organization in Canada exclusively dedicated to advancing breast cancer research.

With a steadfast commitment to preci s ion oncology, we focus on developin g personal ized treatment plans tailored to individual patients’ needs. Through strategic funding initiatives, we aim to accelerate the transition from standard treatment approaches to the new era of personal ized medicine, ultimately striving to match the right plan to the right person at the right time.

Exclusive Focus on Precision Oncology BCC is uniquely dedicated to funding research that advances precision oncology, encompassing areas such as basic science, screening and detection, personalized treatment, and patient-reported outcomes. This targeted approach ensures that funded projects contribute directly to the development of individualized treatment strategies for breast cancer patients.

Researchers have access to a variety of funding programs, including Tier 1 and Tier 2 grants for screening, detection, targeted treatment, and precision diagnostics, with amounts ranging from $50,000 to $75,000 CAD. Additionally, BCC offers specialized grants such as the $1 million Canadian Breast Cancer Cl inical Scienti st Fellows h ip P rog ram and collaborative grants with industry partners like AstraZeneca Canada.

Emphasis on Patient-Centric Research BCC mandates the inclusion of breast cancer patient advocates or local advocacy groups in funded research projects. This requirement ensures that research remains patient-focused, integrating real-world experiences and perspectives to enhance the relevance and impact of scientific findings.

Proven Track Record of Catalyzing Further Funding BCC’s seed funding programs, such as the Breast Cancer Canada Translational Research Unit Scholarships Program, have a history of enabling researchers to secure additional funding from government or industry sources. Recipients often leverage initial BCC grants into significantly larger investments, amplifying the reach and potential impact of their research.

At Breast Cancer Canada, research grants are more than just financial support—they are catalysts for progress that drive meaningful advancements in breast cancer care. These grants enable scientists and clinicians to pursue innovative research that accelerates the development of more accurate diagnostic tools, less invasive treatment options, and more effective therapies with fewer side effects.

Beyond the lab, Breast Cancer Canada’s grant programs also require collaboration with patient advocates, ensuring that research remains grounded in the lived experiences of those affected by the disease. As a result, every grant awarded brings us one step closer to a future where breast cancer is detected earlier, treated more effectively, and understood more completely.

This policy outlines Breast Cancer Canada’s position on the allocation of research grant funding, with specific reference to indirect and overhead costs. Read Breast Cancer Canada's Grant Funding Policy Progress Through Research Breast Cancer Canada donations fund life-saving research that directly impacts Canadian patients.

That means better answers, bigger breakthroughs – and more personalized treatment for every breast cancer diagnosis. Our suite of digital tools are each designed to help individuals better manage their breast cancer journey through education, research and personalized insights, while also elevating the patient voice. Every breast cancer journey is unique, but together, these stories paint a powerful picture of progress.

Through firsthand accounts from patients and survivors, we share stories that highlight the lived-experiences of breast cancer. Progress happens when we invest in it. Canada is home to some of the world’s brightest minds in research.

Together, we are advancing science, ensuring it leads to earlier detection, better treatments, and improved outcomes for patients across the country. Support Breast Cancer Research Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Charitable Registration Number: I agree to receive communications from Breast Cancer Canada I agree to receive communications from Breast Cancer Canada